玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

首頁(yè)
訂購(gòu)/客服:400-666-5481

MBX 8025

    
≥98%

Seladelpar

源葉(MedMol)
S88723 一鍵復(fù)制產(chǎn)品信息
851528-79-5
C21H23F3O5S
444.4645296
貨號(hào) 規(guī)格 價(jià)格 上海 北京 武漢 南京 購(gòu)買數(shù)量
S88723-2mg
≥98% ¥475.00 貨期:2-3天 - - -
S88723-5mg
≥98% ¥740.00 貨期:2-3天 - - -
S88723-10mg
≥98% ¥1230.00 貨期:2-3天 - - -
S88723-25mg
≥98% ¥2350.00 貨期:2-3天 - - -
S88723-50mg
≥98% ¥3900.00 貨期:2-3天 - - -
S88723-100mg
≥98% ¥5700.00 貨期:2-3天 - - -
產(chǎn)品介紹 參考文獻(xiàn) 質(zhì)檢證書(COA) 摩爾濃度計(jì)算器 相關(guān)產(chǎn)品

產(chǎn)品介紹

Seladelpar (MBX-8025) is an orally active, potent (50% effect concentration EC50 2 nM), and specific PPAR-δ agonist

產(chǎn)品描述: Seladelpar (MBX-8025) is an orally active, potent (50% effect concentration EC50 2 nM), and specific PPAR-δ agonist
靶點(diǎn): PPAR-δ:2 nM (EC50);PPAR-α:1600 nM (EC50);PPAR
體外研究: Seladelpar (MBX-8025) is an orally active, potent (2 nM), and specific (>750-fold and >2500-fold compared with PPAR-α or PPAR-γ receptors, respectively) PPAR-δ agonist being developed as a lipid-altering agent. Seladelpar is a potent, and selective PPAR-δ agonist (50% effect concentration human PPAR-δ=2 nM, PPAR-α=1,600 nM) that demonstrates favorable effects on insulin resistance, diabetes, and atherogenic dyslipidemia
體內(nèi)研究: From weaning, female Alms1 mutant (foz/foz) mice and wild-type littermates are fed an atherogenic diet for 16 weeks; groups (n=8-12) are then randomized to receive Seladelpar (10 mg/kg) or vehicle (1% methylcellulose) by gavage for 8 weeks. Despite minimally altering body weight, Seladelpar normalizes hyperglycemia, hyperinsulinemia, and glucose disposal in foz/foz mice. Serum alanine aminotransferase ranges 300-600 U/L in vehicle-treated foz/foz mice; Seladelpar reduces alanine aminotransferase by 50%. In addition, Seladelpar normalizes serum lipids and hepatic levels of free cholesterol and other lipotoxic lipids that are increased in vehicle-treated foz/foz versus wild-type mice. This abolished hepatocyte ballooning and apoptosis, substantially reduce steatosis and liver inflammation, and improve liver fibrosis. In vehicle-treated foz/foz mice, the mean nonalcoholic fatty liver disease activity score is 6.9, indicating nonalcoholic steatohepatitis (NASH); Seladelpar reverses NASH in all foz/foz mice (nonalcoholic fatty liver disease activity score 3.13). In atherogenic diet-fed Wt mice, administration of Seladelpar reduces body weight by ~18% (P<0.05). In contrast, Seladelpar produces minimal effect on body weight in atherogenic diet–fed foz/foz mice. These animals develope severe hyperglycemia, hyperinsulinemia, and whole-body insulin resistance after 16 weeks (P<0.05); Seladelpar strikingly improves these indices (P<0.05). After intraperitoneal glucose injection, blood glucose reaches ~32 mM in
參考文獻(xiàn): 1. Bays HE, et al. MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin. J Clin Endocrinol Metab. 2011 Sep;96(9):2889-97. 2. Haczeyni F, et al. The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice. Hepatol Commun. 2017 Jul 31;1(7):663-674.
溶解性: Soluble  in  DMSO
保存條件: -20°C
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 2.25 ml 11.249 ml 22.499 ml
5 mM 0.45 ml 2.25 ml 4.5 ml
10 mM 0.225 ml 1.125 ml 2.25 ml
50 mM 0.045 ml 0.225 ml 0.45 ml
注意: 部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。

參考文獻(xiàn)

質(zhì)檢證書(COA)

如何獲取質(zhì)檢證書(COA)?
請(qǐng)輸入貨號(hào)和一個(gè)與之匹配的批號(hào)。
例如:
批號(hào):JS298415 貨號(hào):S20001-25g
在貨品標(biāo)簽上如何找到貨號(hào)和批號(hào)?

摩爾濃度計(jì)算器

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×
主站蜘蛛池模板: 绥宁县| 芒康县| 清河县| 吉木萨尔县| 尖扎县| 成武县| 封丘县| 莫力| 纳雍县| 汾阳市| 乐业县| 枣庄市| 日照市| 顺平县| 开封县| 平阴县| 乃东县| 雷波县| 普兰店市| 兴城市| 正定县| 榕江县| 郁南县| 迁安市| 建德市| 砚山县| 牙克石市| 米脂县| 新巴尔虎右旗| 平湖市| 合作市| 阿鲁科尔沁旗| 鸡东县| 定结县| 米脂县| 海盐县| 黄浦区| 庄河市| 太仓市| 集安市| 巍山|